AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2001 JUN 6 - (NewsRx.com & NewsRx.net) --
by N.R. Saltmarsh, staff medical writer - When prescribing antibiotics for pneumococcal infections, clinicians are justifiably nervous about growing resistance problems.
But they may be leaning too far in the other direction if they always choose a new generation or class of antibiotics, say researchers who conducted an extensive review of Medline and other data.
G.W. Amsden and colleagues sought to clarify treatment considerations for Pneumococcus infections in light of growing drug resistance. Their findings were published in the Annals of Pharmacotherapy.
Reports of pneumococcal isolates that are resistant to one or more classes of antibiotics are becoming more frequent, said Amsden and team, resulting in significant shifts in treatment.
But are those treatment decisions being made without carefully weighing all the ramifications?
"Although clinicians have shifted to a new generation or class of antibiotics when faced with a resistance trend, data with resistant pneumococci show that this may not be necessary," said Amsden et al.
Source: HighBeam Research, Careful Therapy Considerations Could Ease Resistance Problems.(Brief...